ARS Pharmaceuticals (SPRY.BOATS) Q1 2026 Earnings

9MarConfirmed
Q4 2025
Q1 2026
-0.52
-0.48
-0.45
-0.41

Details

Expected EPS
-0.42985
Actual EPS
-0.41
Surprise EPS
0.02
Surprise Percent
+4.62%

Description

ARS Pharmaceuticals (SPRY.BOATS) has reported earnings of -0.41 per share for Q1 2026.

0 Comments

Share your thoughts